Skip to the content

support@mellalta.com +1 (304) 470-2225

Home
About Us
Services
Case Studies
Blog
Report Store
Contact Us
- My account
Products search

Menu

Cart

No products in the cart.

View Cart Checkout

High grade intraepithelial lesion

High grade intraepithelial lesion (HSIL) | Primary Research (KOL’s Insight) | Competitive Intelligence | Market Analytics & Forecast 2030
$6,500.00 – $19,500.00 Select options

Search for:

Filter by price

Price: —

Product categories

Market Forecast 39
Pipeline Analytics Report 5
Therapeutic Area 33
- Central Nervous System 11
- Endocrinology 4
- Genetic Diseases 2
- Genetic Disorders 2
- Oncology 10
- Ophthalmology 2
- Pre-cancerous (Infections) 1
- Renal Diseases / Nephrology 3
- Sleep Disorders 1
Therapy Reports 18

Latest Products

Prader-Willi Syndrome (PWS)| Primary Research (KOL's Insight) | Market Intelligence | Epidemiology & Market Forecast-2032 $6,500.00 – $19,500.00
Metastatic Ovarian Cancer (mOC)| Primary Research (KOL's Insight) | Market Intelligence | Epidemiology & Market Forecast-2032 $6,500.00 – $19,500.00
ER+/HER2- Metastatic Breast Cancer (mBC)| Primary Research (KOL's Insight) | Market Intelligence | Epidemiology & Market Forecast-2032 $6,500.00 – $19,500.00

Customised Report

Looking for a customised Report. Send the details to us.

Request for Customised Report

Get In Touch

Let's keep the conversation going

DELIVERING STRATEGIES THAT MAKES THE DIFFERENCE

Mellalta Meets is where imagination meets excellence, we champion the bold and help in achieving companies the extraordinary.

Documents

Fast Facts PDF Document

Financial Information PDF Document

Recent Posts

Menarini’s Upcoming Business Strategies for Elacestrant for Breast Cancer August 30, 2022
Y-mabs’ Danyelza for R/R High-Risk Neuroblastoma: Business & Launch Strategies December 3, 2020

Contact Us

+1 (304) 470-2225
support@mellalta.com

Mellalta Meets - Excellence Reimagined

Copyright 2020